Search results
Results From The WOW.Com Content Network
COVID-19 is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, Mainland China in December 2019 [4] and was confirmed to have spread to Indonesia on 2 March 2020. [5] COVID-19 vaccination in Indonesia will cover more than 75% of overall Indonesian population ...
CoronaVac, also known as the Sinovac COVID-19 vaccine, [3] is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. [4] [5] It was phase III clinically trialled in Brazil, [6] Chile, [7] Indonesia, [8] the Philippines, [9] and Turkey [10] and relies on traditional technology similar to other inactivated ...
The COVID-19 pandemic in Indonesia is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was confirmed to have spread to Indonesia on 2 March 2020, after a dance instructor and her mother tested positive for the virus. Both were infected from a ...
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 , the virus that causes coronavirus disease 2019 . Prior to the COVID‑19 pandemic , an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute ...
Foreigners in Indonesia. As of 27 January 2022, at least 6,190 foreigners were tested positive for COVID-19 in Indonesia, of which 5,840 recovered, 32 died, and 413 had returned to their respective countries or territories. [3]
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
v. t. e. The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, [2] the Sinopharm COVID-19 vaccine, [3] or BIBP vaccine, [3] [4] [5] is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm 's Beijing Institute of Biological Products (sometimes written as Beijing Bio-Institute of Biological Products, [6] resulting ...
For the Netherlands, based on overall excess mortality, an estimated 20,000 people died from COVID-19 in 2020, [9] while only the death of 11,525 identified COVID-19 cases was registered. [8] The official count of COVID-19 deaths as of December 2021 is slightly more than 5.4 million, according to World Health Organization's report in May 2022.